MarketTwits
268K subscribers
79.1K photos
3K videos
1.1K files
83.8K links
Вся информация на канале не является рекомендацией

связь - @MarketTwits_info
связь - [email protected]
VK - https://vk.com/id635239814

№ 4943378258
Download Telegram
🇺🇸#акции #сша #premarket
премаркет США - акции - заметные движения:

ВВЕРХ

#SINT +50% SINTX Technologies - after the company issued a business update.

#MYL +23% Mylan N.V. -after the company announced a business combination with Pfizer's Upjohn division. The company also reported better-than-expected Q2 results.

#KIN +22% Kindred Biosciences, Inc. - after reporting results from pilot field effectiveness study of its Interleukin-31 monoclonal antibody for the treatment of atopic dermatitis in dogs.

#CDTX +16% Cidara Therapeutics Inc- after the company reported topline results from its phase 2 STRIVE B trial of Antifungal Rezafungin. Rezafungin met its objectives for efficacy, safety and tolerability.

#ATHE +16% Alterity Therapeutics Ltd - after the company announced the completion of its Phase 1 clinical trial for PBT434. The drug was safe and well-tolerated, with adverse event rates comparable to placebo.

#SNGX +13% Soligenix, Inc. - after the company received European patents for Oral BDP in the treatment of acute radiation injury of the gastrointestinal tract.

#GHDX +13% Genomic Health, Inc. - after EXACT Sciences Corporation #EXAS announced it will acquire the company for $72 per share. The company also reported better-than-expected Q2 EPS and sales results and raised its FY19 guidance.

#TSEM +10% Tower Semiconductor Ltd. - after the company reported better-than-expected Q2 EPS and sales results.

#PIRS +10% Pieris Pharmaceuticals, Inc. - said on July 26, European Respiratory Society announced acceptance of late-breaking presentation of company's Phase 1 study of PRS-060.

#AVXL +9% Anavex Life Sciences Corp. - after receiving positive opinion for orphan designation from the European Medicines Agency for ANAVEX 2-73 for the treatment of Rett syndrome.

#NIU +9% Niu Technologies- expected to release Q2 earnings on August 23, 2019.

#BAH +7% Booz Allen Hamilton Holding Corporation -after the company reported upbeat Q1 earnings results.

#EQIX +7% Equinix, Inc.

#WSG +7% Wanda Sports Group Company Limited - after falling 35% on Friday.

#SFET +7% Safe-T Group Ltd - after the company announced a Tier-1 collaboration agreement for its IP proxy product with a Korean internet service provider.

#TEVA +6% Teva Pharmaceutical Industries Limited - following a merger between generic drug maker Mylan and Pfizer's off-patent Upjohn division.

#XBIO +6% Xenetic Biosciences, Inc. -after Anson Funds Management LP reported a 9.8% passive stake in the company.

#TCRR +6% TCR2 Therapeutics Inc. -after gaining 5% on Friday.

#SNY +3% Sanofi SA- after the company reported better-than-expected Q2 EPS and sales results.

ВНИЗ

#LXRX -53% Lexicon Pharmaceuticals, Inc. - after the company received a written notice from Sanofi #SNY terminating the agreement for the development and commercialization of the company's Diabetes drug candidate Sotagliflozin.

#CTB -11% Cooper Tire & Rubber Company - after the company reported worse-than-expected Q2 results.

#PTE -11% PolarityTE, Inc. - expected to release Q2 results on August 8..

#EXAS -10% Exact Sciences Corporation - after the company announced it will acquire Genomic Health for $72 per share in cash and stock.

#REKR -7% Rekor Systems, Inc. -after rising 16.85% on Friday.

#AVGO -5% Broadcom Inc.

#OIS -5% Oil States International, Inc. -following downbeat Q2 results.

#SMSI -5% Smith Micro Software, Inc. -after rising 66% on Friday.

#TTM -5% Tata Motors Limited

#RARX -5% Ra Pharmaceuticals, Inc. -Raymond James downgraded Ra Pharmaceuticals from Strong Buy to Market Perform.

#CARB -5% Carbonite, Inc. - after declining 25% on Friday.

#SEAS -4% SeaWorld Entertainment, Inc.

#VEDL -4% Vedanta Limited

#OBLN -4% Obalon Therapeutics, Inc. -after climbing 22% on Friday.

#ACHN -3% Achillion Pharmaceuticals, Inc.-after gaining 18% on Friday.

#DISH -3% DISH Network Corp - after Barclays downgraded the stock from Equal-Weight to Underweight and announced a price target of $31 per share.
💥🇺🇸#вакцина
Kindred Bio #KIN подписал соглашение с Vaxart #VXRT - будут вместе разрабатывать вакцину от COVID
💥🇺🇸#KIN Kindred's antibody shows efficacy and mortality benefit against canine parvovirus